Insider · CIK 0001859018
Hardin Dean Mitchell
Files at ACT (Enact Holdings, Inc.). First filing -, latest -.
In brief
Hardin Dean Mitchell files SEC Form 4 as CFO at ACT (Enact Holdings, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Hardin Dean Mitchell has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
The newest 50 of 56 rows this insider has filed.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 17, 2026 | ACT Enact Holdings, Inc. | AGrant or award Restricted Stock Unitsderivative | +32 | $0.00 | $0 | 6,351 | 22 d ago |
| Sep 17, 2026 | ACT Enact Holdings, Inc. | AGrant or award Restricted Stock Unitsderivative | +51 | $0.00 | $0 | 10,290 | 22 d ago |
| Sep 17, 2026 | ACT Enact Holdings, Inc. | AGrant or award Restricted Stock Unitsderivative | +66 | $0.00 | $0 | 13,375 | 22 d ago |
| Jun 18, 2026 | ACT Enact Holdings, Inc. | AGrant or award Restricted Stock Unitsderivative | +36 | $0.00 | $0 | 6,319 | Jun 23, 2026 |
| Jun 18, 2026 | ACT Enact Holdings, Inc. | AGrant or award Restricted Stock Unitsderivative | +58 | $0.00 | $0 | 10,239 | Jun 23, 2026 |
| Jun 18, 2026 | ACT Enact Holdings, Inc. | AGrant or award Restricted Stock Unitsderivative | +75 | $0.00 | $0 | 13,309 | Jun 23, 2026 |
| Mar 19, 2026 | ACT Enact Holdings, Inc. | AGrant or award Restricted Stock Unitsderivative | +33 | $0.00 | $0 | 6,283 | Mar 23, 2026 |
| Mar 19, 2026 | ACT Enact Holdings, Inc. | AGrant or award Restricted Stock Unitsderivative | +53 | $0.00 | $0 | 10,181 | Mar 23, 2026 |
| Mar 19, 2026 | ACT Enact Holdings, Inc. | AGrant or award Restricted Stock Unitsderivative | +69 | $0.00 | $0 | 13,234 | Mar 23, 2026 |
| Feb 24, 2026 | ACT Enact Holdings, Inc. | MOption exercise Common Stock | +42,616 | - | - | 160,021 | Feb 26, 2026 |
| Feb 24, 2026 | ACT Enact Holdings, Inc. | FTax withholding Common Stock | -17,723 | $41.46 | $735k | 142,298 | Feb 26, 2026 |
| Feb 24, 2026 | ACT Enact Holdings, Inc. | MOption exercise Performance Stock Unitsderivative | -42,616 | $0.00 | $0 | 0 | Feb 26, 2026 |
| Feb 20, 2026 | ACT Enact Holdings, Inc. | MOption exercise Common Stock | +5,068 | - | - | 118,847 | Feb 24, 2026 |
| Feb 20, 2026 | ACT Enact Holdings, Inc. | FTax withholding Common Stock | -1,442 | $41.43 | $60k | 117,405 | Feb 24, 2026 |
| Feb 20, 2026 | ACT Enact Holdings, Inc. | MOption exercise Restricted Stock Unitsderivative | -5,068 | $0.00 | $0 | 10,128 | Feb 24, 2026 |
| Feb 17, 2026 | ACT Enact Holdings, Inc. | MOption exercise Common Stock | +6,262 | - | - | 115,560 | Feb 18, 2026 |
| Feb 17, 2026 | ACT Enact Holdings, Inc. | FTax withholding Common Stock | -1,781 | $43.29 | $77k | 113,779 | Feb 18, 2026 |
| Feb 13, 2026 | ACT Enact Holdings, Inc. | AGrant or award Restricted Stock Unitsderivative | +13,165 | $0.00 | $0 | 13,165 | Feb 18, 2026 |
| Feb 17, 2026 | ACT Enact Holdings, Inc. | MOption exercise Restricted Stock Unitsderivative | -6,262 | $0.00 | $0 | 6,250 | Feb 18, 2026 |
| Feb 9, 2026 | ACT Enact Holdings, Inc. | MOption exercise Common Stock | +7,095 | - | - | 111,470 | Feb 11, 2026 |
| Feb 9, 2026 | ACT Enact Holdings, Inc. | FTax withholding Common Stock | -2,172 | $42.39 | $92k | 109,298 | Feb 11, 2026 |
| Feb 9, 2026 | ACT Enact Holdings, Inc. | MOption exercise Restricted Stock Unitsderivative | -7,095 | $0.00 | $0 | 0 | Feb 11, 2026 |
| Dec 11, 2025 | ACT Enact Holdings, Inc. | AGrant or award Restricted Stock Unitsderivative | +38 | $0.00 | $0 | 7,095 | Dec 15, 2025 |
| Dec 11, 2025 | ACT Enact Holdings, Inc. | AGrant or award Restricted Stock Unitsderivative | +67 | $0.00 | $0 | 12,512 | Dec 15, 2025 |
| Dec 11, 2025 | ACT Enact Holdings, Inc. | AGrant or award Restricted Stock Unitsderivative | +81 | $0.00 | $0 | 15,196 | Dec 15, 2025 |
| Sep 8, 2025 | ACT Enact Holdings, Inc. | AGrant or award Restricted Stock Unitsderivative | +38 | $0.00 | $0 | 7,057 | Sep 10, 2025 |
| Sep 8, 2025 | ACT Enact Holdings, Inc. | AGrant or award Restricted Stock Unitsderivative | +67 | $0.00 | $0 | 12,445 | Sep 10, 2025 |
| Sep 8, 2025 | ACT Enact Holdings, Inc. | AGrant or award Restricted Stock Unitsderivative | +82 | $0.00 | $0 | 15,115 | Sep 10, 2025 |
| Jun 11, 2025 | ACT Enact Holdings, Inc. | AGrant or award Restricted Stock Unitsderivative | +43 | $0.00 | $0 | 7,019 | Jun 13, 2025 |
| Jun 11, 2025 | ACT Enact Holdings, Inc. | AGrant or award Restricted Stock Unitsderivative | +75 | $0.00 | $0 | 12,378 | Jun 13, 2025 |
| Jun 11, 2025 | ACT Enact Holdings, Inc. | AGrant or award Restricted Stock Unitsderivative | +91 | $0.00 | $0 | 15,033 | Jun 13, 2025 |
| Mar 14, 2025 | ACT Enact Holdings, Inc. | MOption exercise Common Stock | +250 | - | - | 104,485 | Mar 18, 2025 |
| Mar 14, 2025 | ACT Enact Holdings, Inc. | FTax withholding Common Stock | -110 | $33.40 | $3,674 | 104,375 | Mar 18, 2025 |
| Mar 14, 2025 | ACT Enact Holdings, Inc. | AGrant or award Restricted Stock Unitsderivative | +39 | $0.00 | $0 | 6,976 | Mar 18, 2025 |
| Mar 14, 2025 | ACT Enact Holdings, Inc. | AGrant or award Restricted Stock Unitsderivative | +68 | $0.00 | $0 | 12,303 | Mar 18, 2025 |
| Mar 14, 2025 | ACT Enact Holdings, Inc. | AGrant or award Restricted Stock Unitsderivative | +83 | $0.00 | $0 | 14,942 | Mar 18, 2025 |
| Mar 14, 2025 | ACT Enact Holdings, Inc. | AGrant or award Performance Stock Unitsderivative | +250 | $0.00 | $0 | 250 | Mar 18, 2025 |
| Feb 24, 2025 | ACT Enact Holdings, Inc. | MOption exercise Common Stock | +45,064 | - | - | 122,552 | Feb 26, 2025 |
| Feb 24, 2025 | ACT Enact Holdings, Inc. | FTax withholding Common Stock | -18,317 | $33.23 | $609k | 104,235 | Feb 26, 2025 |
| Feb 24, 2025 | ACT Enact Holdings, Inc. | AGrant or award Performance Stock Unitsderivative | +45,064 | $0.00 | $0 | 45,064 | Feb 26, 2025 |
| Feb 21, 2025 | ACT Enact Holdings, Inc. | AGrant or award Restricted Stock Unitsderivative | +14,859 | $0.00 | $0 | 14,859 | Feb 25, 2025 |
| Feb 18, 2025 | ACT Enact Holdings, Inc. | MOption exercise Common Stock | +6,120 | - | - | 79,245 | Feb 19, 2025 |
| Feb 18, 2025 | ACT Enact Holdings, Inc. | FTax withholding Common Stock | -1,757 | $33.60 | $59k | 77,488 | Feb 19, 2025 |
| Feb 18, 2025 | ACT Enact Holdings, Inc. | MOption exercise Restricted Stock Unitsderivative | -6,120 | $0.00 | $0 | 12,235 | Feb 19, 2025 |
| Feb 11, 2025 | ACT Enact Holdings, Inc. | MOption exercise Common Stock | +7,507 | - | - | 75,280 | Feb 13, 2025 |
| Feb 11, 2025 | ACT Enact Holdings, Inc. | FTax withholding Common Stock | -2,155 | $33.79 | $73k | 73,125 | Feb 13, 2025 |
| Feb 11, 2025 | ACT Enact Holdings, Inc. | MOption exercise Restricted Stock Unitsderivative | -7,507 | $0.00 | $0 | 0 | Feb 13, 2025 |
| Feb 7, 2025 | ACT Enact Holdings, Inc. | MOption exercise Common Stock | +6,952 | - | - | 69,945 | Feb 11, 2025 |
| Feb 7, 2025 | ACT Enact Holdings, Inc. | FTax withholding Common Stock | -2,172 | $33.91 | $74k | 67,773 | Feb 11, 2025 |
| Feb 7, 2025 | ACT Enact Holdings, Inc. | MOption exercise Restricted Stock Unitsderivative | -6,952 | $0.00 | $0 | 6,937 | Feb 11, 2025 |
Questions about Hardin Dean Mitchell
Answered from the filings on this page, as of the latest one.
Is Hardin Dean Mitchell buying or selling?
Hardin Dean Mitchell has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Hardin Dean Mitchell's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Hardin Dean Mitchell has 0.
Where does Hardin Dean Mitchell file Form 4?
Hardin Dean Mitchell has filed Form 4 at ACT (Enact Holdings, Inc.) as EVP, CFO and Treasurer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.